The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangiocarcinoma as Second-Line and Successive Treatment: A Real-World Study

Table 3

Adverse events and frequency.

AEs	Grade 1–2	Frequency (%)	Grade 3–4	Frequency (%)	Total frequency (%)
Nausea	7	77.8	0	0.0	77.8
Vomiting	6	66.7	1	11.1	77.8
Hair loss	2	22.2	0	0.0	22.2
Oral ulceration	1	11.1	0	0.0	11.1
Hyperbilirubinemia	3	33.3	2	22.2	55.6
Elevated ALT	2	22.2	2	22.2	44.4
Elevated AST	2	22.2	2	22.2	44.4
Ascite	0	0.0	2	22.2	22.2
Weight loss	1	11.1	0	0.0	11.1
Embolus	1	11.1	0	0.0	11.1